Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001159036-25-000075
Filing Date
2025-12-19
Accepted
2025-12-19 17:39:43
Documents
1
Period of Report
2025-11-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1766183980.html 4  
1 FORM 4 wk-form4_1766183980.xml 4 6835
  Complete submission text file 0001159036-25-000075.txt   8495
Mailing Address 12390 EL CAMINO REAL SAN DIEGO CA 92130
Business Address 12390 EL CAMINO REAL SAN DIEGO CA 92130 (858) 794-8889
HALOZYME THERAPEUTICS, INC. (Issuer) CIK: 0001159036 (see all company filings)

EIN.: 880488686 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O HALOZYME THERAPEUTICS, INC. 12390 EL CAMINO REAL SAN DIEGO CA 92130
Business Address
Caudill Cortney (Reporting) CIK: 0002090209 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32335 | Film No.: 251588708